This leader will be an embedded, working member of the cross-functional program team-alongside Clinical Development, Clinical Operations, Regulatory Affairs, Medical Affairs, Translational Medicine and Program Management-authoring and owning statistical analysis plans, defining estimands, performing analyses and driving the statistical content of protocols, health-authority interactions and scientific presentations. Reporting to the VP, Program Management and Head of Clinical Trial Services, the Senior Director / Executive Director, Biostatistics will lead the biostatistics strategy for the NKX019 autoimmune program-from ongoing multi-indication Phase 1/2 studies through potential pivotal trial design-and will be Nkarta's most senior statistical voice with the FDA, the Board, investigators, partners and the scientific community.